Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Moodys
AstraZeneca
Merck
McKesson

Last Updated: May 31, 2023

Drug Sales Trends for GRALISE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Payment Methods and Pharmacy Types for GRALISE (2020)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $27,689,927
INSIDE ANOTHER STORE $58,698,241
[disabled in preview] $116,057,809
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 96,709
INSIDE ANOTHER STORE 209,702
[disabled in preview] 436,217
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $52,900,755
MEDICARE $2,662,112
[disabled in preview] $146,883,108
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for GRALISE
Drug Units Sold Trends for GRALISE

Annual Sales Revenues and Units Sold for GRALISE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
GRALISE ⤷  Try a Trial ⤷  Try a Trial 2019
GRALISE ⤷  Try a Trial ⤷  Try a Trial 2018
GRALISE ⤷  Try a Trial ⤷  Try a Trial 2017
GRALISE ⤷  Try a Trial ⤷  Try a Trial 2016
GRALISE ⤷  Try a Trial ⤷  Try a Trial 2015
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Mallinckrodt
Moodys
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.